29: From Monoclonals to Gene Therapy: Tips for Biopharma Process Development w/ Neil Templeton - Part 1
02/20/24 • 23 min
In this enlightening episode, we're joined by Neil Templeton, Director in Upstream Process Development at Solid Biosciences, who pulls back the curtain on the intricate world of bioprocess development and manufacturing.
Neil delves into the shifting paradigms of the industry, sharing his expert insights on overcoming the unique challenges that surface when transitioning from R&D to GMP production. This episode is packed full of invaluable knowledge that's crucial for anyone looking to succeed in this field.
Key points we discuss include:
- Strategies and solutions for overcoming the obstacles faced when transitioning from R&D to GMP production.
- The importance and application of Design of Experiment (DOE) approaches, and their role in understanding critical process parameters.
- The role of metabolite analysis in optimizing processes and ensuring their robustness.
Get connected with Neil Templeton:
LinkedIn: https://www.linkedin.com/in/neil-templeton
Next Step:
Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.com
In this enlightening episode, we're joined by Neil Templeton, Director in Upstream Process Development at Solid Biosciences, who pulls back the curtain on the intricate world of bioprocess development and manufacturing.
Neil delves into the shifting paradigms of the industry, sharing his expert insights on overcoming the unique challenges that surface when transitioning from R&D to GMP production. This episode is packed full of invaluable knowledge that's crucial for anyone looking to succeed in this field.
Key points we discuss include:
- Strategies and solutions for overcoming the obstacles faced when transitioning from R&D to GMP production.
- The importance and application of Design of Experiment (DOE) approaches, and their role in understanding critical process parameters.
- The role of metabolite analysis in optimizing processes and ensuring their robustness.
Get connected with Neil Templeton:
LinkedIn: https://www.linkedin.com/in/neil-templeton
Next Step:
Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.com
Previous Episode
28: How to Simplify Project Management in Bioprocess Development - Part 2
Tackling bioprocess development and scale-up can be complex. While the science might be challenging, project management within biotech doesn't have to be.
In this engaging episode, we'll guide you on how to streamline your CMC development, demystifying the complexities of project planning and execution.
Here's what you'll gain:
- Discover the secret to 'Successful Planning,' - a strategy to ensure your projects are well-organised, resource-smart, and timely delivered.
- Understand the crucial role of 'Assessing Scalability Potential,' and why it's a game-changer for your project's long-term success.
- Unleash the 'Power of a High-Performance Team,' and learn how effective leadership can enable your team to excel and achieve outstanding results.
Don't allow complexity to impede your progress - join us for these insights and beyond!
Next Step:
Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.com
Next Episode
30: From Monoclonals to Gene Therapy: Tips for Biopharma Process Development w/ Neil Templeton - Part 2
In our insightful second part of the conversation, we broaden our perspective to delve into the various modalities within the biotech industry, highlighting the unique and shared aspects of process development and scale-up.
Neil Templeton, the Director of Upstream Process Development at Solid Biosciences, passionately articulates his commitment towards making gene therapy more accessible. He does this by outlining strategic solutions to reduce the costs of development and manufacturing.
You will gain:
- A comprehensive understanding of process development's similarities and differences across biologics, vaccines, and cell and gene therapy manufacturing.
- Effective strategies aimed at reducing the costs associated with gene therapy development and manufacturing.
- Insights into how capitalizing on the expertise from the biologics sector can positively impact other fields.
To connect with Neil Templeton and learn more about his work, visit his LinkedIn profile.
LinkedIn: https://www.linkedin.com/in/neil-templeton
Next Step:
Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.com
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/smart-biotech-scientist-master-bioprocess-cmc-development-biologics-ma-320725/29-from-monoclonals-to-gene-therapy-tips-for-biopharma-process-develop-46955104"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 29: from monoclonals to gene therapy: tips for biopharma process development w/ neil templeton - part 1 on goodpods" style="width: 225px" /> </a>
Copy